Qa-1-restricted CD8+ Tregs have primarily been studied in the context of autoimmune diseases such as EAE and systemic lupus erythematosus, where these CD8+ Tregs suppress autoreactive CD4+ T cells in an antigen-specific manner and protect against disease progression [24, 41]. Here, CD8A is linked to autoimmune disease.